Waterloo Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
7,945
-248
-3% -$19.1K 0.04% 286
2025
Q4
$650K Sell
8,193
-100
-1% -$7.88K 0.05% 259
2025
Q3
$625K Buy
8,293
+1,027
+14% +$70.4K 0.05% 240
2025
Q2
$501K Sell
7,266
-808
-10% -$53K 0.04% 270
2025
Q1
$547K Sell
8,074
-769
-9% -$46K 0.05% 235
2024
Q4
$397K Sell
8,843
-236
-3% -$13.2K 0.04% 262
2024
Q3
$571K Sell
9,079
-32,489
-78% -$1.9M 0.06% 216
2024
Q2
$2.45M Sell
41,568
-588
-1% -$36.8K 0.29% 84
2024
Q1
$3.36M Buy
42,156
+10,252
+32% +$783K 0.43% 57
2023
Q4
$2.52M Buy
+31,904
New +$2.27M 0.41% 57

Other funds holding CVS

Waterloo Capital's CVS Position: Q1 2026 in Review

Waterloo Capital reduced its CVS Health (CVS) stake by 3% in Q1 2026, selling an estimated $19.1K and leaving 7,945 shares worth $571K. The position accounts for 0.04% of the portfolio, ranked #286.

Waterloo Capital first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.36M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Waterloo Capital held 7,945 shares of CVS Health worth $571K as of Q1 2026.
  • Waterloo Capital sold 248 CVS Health shares in Q1 2026, an estimated $19.1K.
  • CVS Health made up 0.04% of Waterloo Capital's portfolio in Q1 2026, its #286 holding.
  • Waterloo Capital first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Waterloo Capital's CVS Health position peaked at $3.36M in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.